Interplay between copy number alterations and immune profiles in the early breast cancer Scandinavian Breast Group 2004-1 randomized phase II trial: results from a feasibility study
暂无分享,去创建一个
J. Bergh | J. Hartman | D. Rimm | B. Ács | T. Foukakis | N. Crosetto | Yalai Bai | I. Zerdes | A. Matikas | A. Mezheyeuski | Michele Simonetti | Pablo Moreno-Ruiz | L. Harbers | Ceren Boyaci | Ning Zhang | Dimitrios Salgkamis | Susanne Agartz